SMTL ID : 6efj.1

Crystal structure of NDM-1 with compound 9

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.65 Å

Oligo State

monomer

Ligands

2 x ZN: ZINC ION(Non-covalent)

ZN.1: 5 residues within 4Å: Chain A: H.83, H.85, H.152, C.171 Ligands: ZN.2 4 PLIP interactions: 3 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:H.83, A:H.85, A:H.152, H2O.2 ZN.2: 5 residues within 4Å: Chain A: D.87, C.171, H.213 Ligands: ZN.1, O5E.3 4 PLIP interactions: 3 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:D.87, A:C.171, A:H.213, H2O.2

1 x O5E: (2R)-2-phenyl-2-(phenylamino)-N-(1H-tetrazol-5-yl)acetamide(Non-covalent)

O5E.3: 12 residues within 4Å: Chain A: L.28, W.56, Q.86, D.87, H.152, C.171, K.174, L.181, G.182, N.183, H.213 Ligands: ZN.2 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.28, A:N.183 Hydrogen bonds: A:K.174, A:N.183 Water bridges: A:D.87, A:N.183 pi-Stacking: A:W.56

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Torelli, N.J. et al., Active-Site Druggability of Carbapenemases and Broad-Spectrum Inhibitor Discovery. Acs Infect Dis. (2019)

Release Date

2019-04-17

Peptides

Metallo-beta-lactamase type 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Metallo-beta-lactamase type 2

Related Entries With Identical Sequence